贛鋒鋰業(002460.SZ):2.4億港元入股鉭鈮行業龍頭稀美資源 佔股16.7%
格隆匯5月20日丨贛鋒鋰業(002460.SZ)公佈,公司通過全資孫公司GFL Investment與稀美資源(09936.HK)及中國銀河國際證券(香港)有限公司簽署了框架股份認購協議,GFL Investment擬以每股4.0港元價格認購稀美資源發行的6000萬股新股份,股權認購的總金額為約合2.4億港元。該次交易完成後,GFL Investment將持有稀美資源約16.7%的股份。
稀美資源是全球主要的鉭鈮生產企業,濕法產能位居世界前列。稀美資源致力於成為世界領先的鉭鈮製造運營商,為航天航空、汽車、電子、國防、醫療及超合金等各行業客户提供專業和優質的解決方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.